Pharmacological treatment for infectious corneal ulcers

Research output: Contribution to journalReview article

13 Scopus citations

Abstract

Introduction: Cornea ulceration and infectious keratitis are leading causes of corneal morbidity and blindness. Infectious causes are among the most frequent and most severe. Management strategies for bacterial corneal ulcers have changed significantly over the last decades, however with a more limited progress in the treatment and management of nonbacterial, infectious ulcers. Areas covered: This paper provides an overview of the current principles, strategies and treatment choices for infectious corneal ulcers in adults. Expert opinion: Topical application with a broad-spectrum antimicrobial remains the preferred method for the pharmacological management of infectious corneal ulcers. Increasing reports of clinical failures and in vitro resistance to antibiotics to treat the most common infectious (bacterial) corneal ulcers are increasing concerns. New approaches for improvement in the pharmacological management of corneal ulcers should focus on strategies for a more rational and evidence-based use of current antimicrobials and development of products to modulate the host immune response and to neutralize microbial toxins and other immune modulators.

Original languageEnglish (US)
Pages (from-to)543-560
Number of pages18
JournalExpert Opinion on Pharmacotherapy
Volume14
Issue number5
DOIs
StatePublished - Apr 1 2013

Keywords

  • Cornea ulcer
  • Fluoroquinolones
  • Pharmacodynamics
  • Pharmacokinetics

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology

Fingerprint Dive into the research topics of 'Pharmacological treatment for infectious corneal ulcers'. Together they form a unique fingerprint.

  • Cite this